Polar Capital Global Healthcare Trust Plc Price/Sales
What is the Price/Sales of Polar Capital Global Healthcare Trust Plc?
The Price/Sales of Polar Capital Global Healthcare Trust Plc is 5.41
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Finance sector on LSE compared to Polar Capital Global Healthcare Trust Plc
What does Polar Capital Global Healthcare Trust Plc do?
Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests in dividend paying growth stocks of large-cap companies having a market capitalization greater than US $5 billion. It employs fundamental analysis with a bottom up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI ACWI/Health Care Index. It was formerly known as Polar Capital Global Healthcare Growth and Income Trust plc. Polar Capital Global Healthcare Trust plc was formed on May 12, 2010 and is domiciled in the United Kingdom.
Companies with price/sales similar to Polar Capital Global Healthcare Trust Plc
- OP Investments has Price/Sales of 5.40
- SITE Centers Corp has Price/Sales of 5.40
- ICICI Securities has Price/Sales of 5.40
- Brookfield Select Opportunities Income Fund has Price/Sales of 5.40
- OptimizeRx has Price/Sales of 5.40
- Broadcom Inc has Price/Sales of 5.41
- Polar Capital Global Healthcare Trust Plc has Price/Sales of 5.41
- Neurocrine Biosciences has Price/Sales of 5.41
- West Bancorporation has Price/Sales of 5.41
- MEDIAN Technologies SA has Price/Sales of 5.42
- Gimv NV has Price/Sales of 5.42
- Hammerson Plc has Price/Sales of 5.42
- ELANTAS Beck India has Price/Sales of 5.42